Provided by Tiger Fintech (Singapore) Pte. Ltd.

RAPT Therapeutics, Inc.

0.8786
+0.00420.48%
Post-market: 0.8775-0.0011-0.13%18:26 EDT
Volume:767.14K
Turnover:661.85K
Market Cap:115.98M
PE:-0.28
High:0.8923
Open:0.8500
Low:0.8168
Close:0.8744
Loading ...
Aug 26, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 14, 2020

Major Issues Report

8-K - Current report
Aug 13, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 22, 2020

Major Issues Report

8-K - Current report
May 29, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
May 14, 2020

Major Issues Report

8-K - Current report
May 14, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 30, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 30, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Feb 24, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
Feb 04, 2020

Correspondence

CORRESP [Cover] - Correspondence
Feb 04, 2020

Public Prospectus

General form for registration of securities under the Securities Act of 1933
Jan 09, 2020

Major Issues Report

Current report, items 7.01 and 9.01
Dec 11, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Dec 11, 2019

Major Issues Report

Current report, items 2.02 and 9.01